A detailed history of Creative Planning transactions in Neogenomics Inc stock. As of the latest transaction made, Creative Planning holds 17,651 shares of NEO stock, worth $242,348. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,651
Previous 16,904 4.42%
Holding current value
$242,348
Previous $273,000 1.47%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$14.06 - $16.79 $10,502 - $12,542
747 Added 4.42%
17,651 $277,000
Q4 2023

Feb 14, 2024

SELL
$11.67 - $20.73 $993,210 - $1.76 Million
-85,108 Reduced 83.43%
16,904 $273,000
Q3 2023

Nov 16, 2023

BUY
$12.15 - $17.85 $13,122 - $19,278
1,080 Added 1.07%
102,012 $1.25 Million
Q2 2023

Jul 21, 2023

SELL
$14.1 - $19.83 $7,980 - $11,223
-566 Reduced 0.56%
100,932 $1.62 Million
Q1 2023

May 15, 2023

SELL
$9.09 - $19.45 $63 - $136
-7 Reduced 0.01%
101,498 $1.77 Million
Q4 2022

Feb 10, 2023

BUY
$6.45 - $12.07 $233,928 - $437,754
36,268 Added 55.59%
101,505 $937,000
Q3 2022

Nov 03, 2022

BUY
$7.86 - $12.91 $320,357 - $526,185
40,758 Added 166.5%
65,237 $562,000
Q2 2022

Aug 15, 2022

BUY
$7.06 - $13.97 $89,852 - $177,796
12,727 Added 108.3%
24,479 $200,000
Q1 2022

May 16, 2022

SELL
$12.15 - $35.28 $2,697 - $7,832
-222 Reduced 1.85%
11,752 $143,000
Q4 2021

Feb 11, 2022

SELL
$30.49 - $48.49 $53,022 - $84,324
-1,739 Reduced 12.68%
11,974 $409,000
Q3 2021

Nov 10, 2021

SELL
$41.66 - $52.52 $266,707 - $336,233
-6,402 Reduced 31.83%
13,713 $662,000
Q2 2021

Aug 04, 2021

BUY
$36.62 - $51.69 $310,208 - $437,865
8,471 Added 72.75%
20,115 $908,000
Q1 2021

Apr 30, 2021

BUY
$41.56 - $59.88 $134,155 - $193,292
3,228 Added 38.36%
11,644 $562,000
Q4 2020

Jan 29, 2021

BUY
$36.08 - $56.47 $40,229 - $62,964
1,115 Added 15.27%
8,416 $453,000
Q3 2020

Nov 05, 2020

BUY
$33.26 - $40.48 $242,831 - $295,544
7,301 New
7,301 $269,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.73B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.